​

Qiagen (QGEN) Stock Forecast, Price Target & Predictions

OverviewOwnershipChartTranscripts

QGEN Stock Forecast

Qiagen (QGEN) stock forecast, based on 29 Wall Street analysts, predicts a 12-month average price target of $54.33, with a high of $59.00 and a low of $50.00. This represents a 33.65% increase from the last price of $40.65.

$40 $44 $48 $52 $56 $60 High: $59 Avg: $54.33 Low: $50 Last Closed Price: $40.65

QGEN Stock Rating

Qiagen stock's rating consensus is Hold, based on 29 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 12 Buy (41.38%), 17 Hold (58.62%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Hold
Total 29 17 12 0 Strong Sell Sell Hold Buy Strong Buy

QGEN Price Target Upside V Benchmarks

TypeNameUpside
StockQiagen33.65%
SectorHealthcare Stocks 15.45%
IndustryDiagnostics & Research Stocks32.46%

Price Target Trends

1M3M12M
# Anlaysts-68
Avg Price Target-$54.33$54.25
Last Closing Price$40.65$40.65$40.65
Upside/Downside-33.65%33.46%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 263311--17
Feb, 263211--16
Jan, 263310--16
Dec, 25349--16
Nov, 25349--16
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 09, 2026UBS$52.00$50.952.06%27.92%
Feb 06, 2026Cathy Ramsey SchulteRobert W. Baird$53.00$51.173.58%30.38%
Feb 06, 2026Stifel Nicolaus$50.00$51.25-2.44%23.00%
Feb 06, 2026Barclays$58.00$51.2313.21%42.68%
Feb 05, 2026Jefferies$59.00$51.2315.17%45.14%
Jan 22, 2026Jan KochDeutsche Bank$54.00$55.66-2.98%32.84%
Dec 15, 2025Barclays$55.00$45.2621.52%35.30%
Oct 02, 2025Catherine Ramsey SchulteBarclays$53.00$46.3214.42%30.38%
Oct 17, 2024Shubhangi GuptHSBC$49.00$43.2113.40%20.54%
Jun 27, 2024Doug SchenkelWolfe Research$50.00$41.2121.33%23.00%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Feb 06, 2026Cowen & Co.HoldHoldhold
Feb 06, 2026BarclaysOverweightOverweighthold
Feb 05, 2026JefferiesBuyBuyhold
Jan 22, 2026Deutsche BankHolddowngrade
Jan 21, 2026UBSNeutralNeutralhold
Dec 15, 2025BarclaysOverweightOverweighthold
Dec 11, 2025CitigroupBuyNeutraldowngrade
Oct 02, 2025BarclaysOverweightOverweighthold
Aug 07, 2025Cowen & Co.HoldHoldhold
Oct 17, 2024HSBCHolddowngrade

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$2.26$1.86$1.52-----
Avg Forecast$2.58$2.37$2.16$2.24$2.35$2.57$2.81$3.09
High Forecast$2.63$2.43$2.17$2.26$2.40$3.21$3.42$3.19
Low Forecast$2.56$2.34$2.14$2.23$2.32$2.22$2.41$3.03
Surprise %-12.40%-21.52%-29.63%-----

Revenue Forecast

$2B $2B $2B $2B $3B $3B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$2.25B$2.14B$1.97B-----
Avg Forecast$2.20B$2.13B$1.96B$1.98B$2.07B$2.21B$2.36B$2.55B
High Forecast$2.23B$2.17B$1.97B$1.99B$2.08B$2.22B$2.44B$2.62B
Low Forecast$2.18B$2.11B$1.95B$1.97B$2.06B$2.20B$2.29B$2.52B
Surprise %2.51%0.32%0.29%-----

Net Income Forecast

$250M $360M $470M $580M $690M $800M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$512.60M$423.21M$341.30M-----
Avg Forecast$461.91M$468.16M$341.30M$501.23M$527.26M$507.09M$584.75M$690.40M
High Forecast$554.29M$561.79M$409.56M$504.67M$536.47M$718.54M$765.12M$713.37M
Low Forecast$369.53M$374.53M$273.04M$497.78M$518.05M$496.08M$539.23M$677.85M
Surprise %10.97%-9.60%------

QGEN Forecast FAQ

Is Qiagen stock a buy?

Qiagen stock has a consensus rating of Hold, based on 29 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 12 Buy, 17 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Qiagen is a neutral investment for most analysts.

What is Qiagen's price target?

Qiagen's price target, set by 29 Wall Street analysts, averages $54.33 over the next 12 months. The price target range spans from $50 at the low end to $59 at the high end, suggesting a potential 33.65% change from the previous closing price of $40.65.

How does Qiagen stock forecast compare to its benchmarks?

Qiagen's stock forecast shows a 33.65% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the diagnostics & research stocks industry (32.46%).

What is the breakdown of analyst ratings for Qiagen over the past three months?

  • March 2026: 17.65% Strong Buy, 17.65% Buy, 64.71% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 18.75% Strong Buy, 12.50% Buy, 68.75% Hold, 0% Sell, 0% Strong Sell.
  • January 2026: 18.75% Strong Buy, 18.75% Buy, 62.50% Hold, 0% Sell, 0% Strong Sell.

What is Qiagen’s EPS forecast?

Qiagen's average annual EPS forecast for its fiscal year ending in December 2024 is $2.24, marking a 47.37% increase from the reported $1.52 in 2023. Estimates for the following years are $2.35 in 2025, $2.57 in 2026, $2.81 in 2027, and $3.09 in 2028.

What is Qiagen’s revenue forecast?

Qiagen's average annual revenue forecast for its fiscal year ending in December 2024 is $1.98B, reflecting a 0.69% increase from the reported $1.97B in 2023. The forecast for 2025 is $2.07B, followed by $2.21B for 2026, $2.36B for 2027, and $2.55B for 2028.

What is Qiagen’s net income forecast?

Qiagen's net income forecast for the fiscal year ending in December 2024 stands at $501.23M, representing an 46.86% increase from the reported $341.3M in 2023. Projections indicate $527.26M in 2025, $507.09M in 2026, $584.75M in 2027, and $690.4M in 2028.